Literature DB >> 18045861

Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.

Nhat M Pham1, Natalie S Recht, Thomas H Hostetter, Timothy W Meyer.   

Abstract

BACKGROUND AND OBJECTIVES: Protein-bound solutes are poorly cleared by peritoneal dialysis. We examined the hypothesis that plasma concentrations of bound solutes would therefore rise as residual renal function is lost. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Clearances of urea indican and p-cresol sulfate were measured in peritoneal dialysis patients with and without residual function.
RESULTS: In patients with residual function, protein binding restricted the peritoneal indican and p-cresol sulfate clearances to 0.3 +/- 0.1 ml/min, as compared to the peritoneal urea clearance of 5.5 +/- 1.1 ml/min. The urinary indican and p-cresol sulfate clearances of 2.7 +/- 2.5 and 1.3 +/- 1.0 ml/min were closer to the urinary urea clearance of 3.9 +/- 2.2 ml/min, reflecting the superior ability of native kidney function to clear bound solutes. Urinary clearance thus provided the majority of the total indican and p-cresol sulfate clearances of 3.0 +/- 2.5 and 1.6 +/- 1.0 ml/min in patients with residual function but the minority of total urea clearance of 9.4 +/- 2.2 ml/min. Loss of residual function lowered the total clearances for indican and p-cresol sulfate to 0.5 +/- 0.2 and 0.4 +/- 0.2 ml/min, whereas the urea clearance fell only slightly. However there was only a modest increase in the plasma indican level and no increase in the plasma p-cresol sulfate level in patients with no residual function because reduction in the daily removal of these solutes accompanied the reduction in their total clearance rates.
CONCLUSIONS: Reduction in the removal of indican and p-cresol sulfate kept plasma levels from rising markedly when residual function was lost.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045861      PMCID: PMC2390983          DOI: 10.2215/CJN.02570607

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  22 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study.

Authors:  P Evenepoel; B Bammens; K Verbeke; Y Vanrenterghem
Journal:  Kidney Int       Date:  2006-05-10       Impact factor: 10.612

Review 3.  Uremic toxicity: urea and beyond.

Authors:  T A Depner
Journal:  Semin Dial       Date:  2001 Jul-Aug       Impact factor: 3.455

Review 4.  Protein-bound uremic retention solutes.

Authors:  Philippe Brunet; Laetitia Dou; Claire Cerini; Yvon Berland
Journal:  Adv Ren Replace Ther       Date:  2003-10

5.  Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.

Authors:  Riccardo Maria Fagugli; Rita De Smet; Umberto Buoncristiani; Norbert Lameire; Raymond Vanholder
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

Review 6.  Protein-bound uremic solutes: the forgotten toxins.

Authors:  R Vanholder; R De Smet; N Lameire
Journal:  Kidney Int Suppl       Date:  2001-02       Impact factor: 10.545

7.  Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study.

Authors:  Bert Bammens; Pieter Evenepoel; Kristin Verbeke; Yves Vanrenterghem
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

8.  Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.

Authors:  Bert Bammens; Pieter Evenepoel; Kristin Verbeke; Yves Vanrenterghem
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

9.  Evidence for impaired assimilation of protein in chronic renal failure.

Authors:  Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

10.  Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes.

Authors:  Timothy W Meyer; Evonne C Leeper; Derek W Bartlett; Thomas A Depner; Yiming Zhao Lit; Channing R Robertson; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

View more
  30 in total

1.  Contribution of residual function to removal of protein-bound solutes in hemodialysis.

Authors:  Ilian O Marquez; Shouieb Tambra; Frank Y Luo; You Li; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes?

Authors:  Raymond Vanholder; Natalie Meert; Wim Van Biesen; Timothy Meyer; Thomas Hostetter; Annemieke Dhondt; Sunny Eloot
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

3.  Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors:  Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

4.  Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Authors:  Liesbeth Viaene; Björn K I Meijers; Bert Bammens; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Perit Dial Int       Date:  2013-10-31       Impact factor: 1.756

Review 5.  Once upon a time in dialysis: the last days of Kt/V?

Authors:  Raymond Vanholder; Griet Glorieux; Sunny Eloot
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

Review 6.  Searching for uremic toxins.

Authors:  Mirela Dobre; Timothy W Meyer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

7.  Can oral therapy reduce uremic toxins?

Authors:  Thomas A Depner; Larry D Cowgill
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 8.237

8.  Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over Study.

Authors:  Sunny Eloot; Raymond Vanholder; Clement Dequidt; Wim Van Biesen
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 9.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

10.  White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease.

Authors:  Caroline C Pelletier; Laetitia Koppe; Marine L Croze; Emilie Kalbacher; Roxane E Vella; Fitsum Guebre-Egziabher; Alain Géloën; Lionel Badet; Denis Fouque; Christophe O Soulage
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.